A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…
Read More
Unraveling Nature’s Pharmacy: Scientists Decode Bacterial Secrets to Manufacturing Potent Cancer Drugs
For decades, the intricate molecular machinery within bacteria has held a tantalizing secret: how these microscopic organisms naturally produce a…
Read More
Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Advertising of Obesity Drugs
The escalating rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly has reached a new legal frontier, with Novo Nordisk…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potential treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast, untapped reservoir…
Read More
Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…
Read More
Scientists Uncover Bacterial Secret to Manufacturing Diverse Cancer Drugs
In a groundbreaking discovery that promises to accelerate the development of novel cancer therapies, scientists have elucidated the intricate molecular…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potential treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast, untapped reservoir…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…
Read More
GLP-1R Weight Loss Drugs May Alleviate Depression Through Gut Microbiome-Endocannabinoid-Brain Axis
Emerging evidence has consistently suggested that glucagon-like peptide-1 receptor (GLP-1R) weight loss drugs, initially developed for metabolic conditions, may offer…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read MoreYOU MAY HAVE MISSED
